Literature DB >> 6335238

Human lymphocyte antigen DR types in relation to early clinical manifestations in diabetic children.

J Ludvigsson, B Lindblom.   

Abstract

Human lymphocyte antigen (HLA)-DR-typing was performed in 117 insulin-dependent diabetics with age at onset between 0.5 and 17 years (mean +/- SD, 9.0 +/- 3.9); 115 of 117 patients were DR3- and/or DR4-positive. DR4 was very common, seen alone or in combination with other DR types in 82.9% of the patients. Only two children were DR2-positive, but they also were DR4-positive. A comparison between DR3 and DR4 patients showed that DR4 patients manifested a seasonal variation of onset (most common onset during spring and autumn), had more severe signs and symptoms of the disease at onset, and were less likely to have a partial remission than patients with DR3. The results support the hypothesis that insulin-dependent diabetes mellitus is a genetically heterogeneous disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6335238     DOI: 10.1203/00006450-198412000-00002

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  3 in total

Review 1.  Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus.

Authors:  G Thomson; W P Robinson; M K Kuhner; S Joe; M J MacDonald; J L Gottschall; J Barbosa; S S Rich; J Bertrams; M P Baur
Journal:  Am J Hum Genet       Date:  1988-12       Impact factor: 11.025

2.  HLA-DR 3 is associated with a more slowly progressive form of type 1 (insulin-dependent) diabetes.

Authors:  J Ludvigsson; U Samuelsson; C Beauforts; I Deschamps; H Dorchy; A Drash; R Francois; G Herz; M New; E Schober
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

3.  Seasonality of type 1 (insulin-dependent) diabetes mellitus: values of C-peptide, insulin antibodies and haemoglobin A1c show evidence of a more rapid loss of insulin secretion in epidemic patients.

Authors:  J Ludvigsson; A O Afoke
Journal:  Diabetologia       Date:  1989-02       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.